Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301140 · ClinicalTrials.gov registry record
Vivistim Registry for Paired VNS Therapy (GRASP)
A clinical trial of Upper Extremity Problem, sponsored by MicroTransponder.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT05301140 is a study of Upper Extremity Problem that is actively recruiting participants, run by MicroTransponder. The registered enrollment target is 1,000 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05301140, a study of Upper Extremity Problem, is actively recruiting participants, sponsored by MicroTransponder.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.
Conditions Studied
Interventions
- DEVICE Vivistim System
Study Locations (2)
New York
- Mt. Sinai - New York
Pennsylvania
- Thomas Jefferson - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05301140
The ClinicalTrials.gov registry entry for NCT05301140 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MicroTransponder, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Extremity Problem appearing as the primary indexed condition, and to 1 intervention - of which Vivistim System is the first listed.
NCT05301140 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05301140 about?
NCT05301140 is a clinical study titled "Vivistim Registry for Paired VNS Therapy (GRASP)". The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout t...
What is the current status of trial NCT05301140?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-03-15. Estimated completion is 2028-12-31.
What conditions does trial NCT05301140 study?
This clinical trial studies the following conditions: Upper Extremity Problem.
What interventions are being tested in trial NCT05301140?
The interventions under investigation include: Vivistim System (DEVICE).
Who is sponsoring clinical trial NCT05301140?
This trial is sponsored by MicroTransponder, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301140 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Extremity Problem
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.